rs4697055

Variant names:

• chr4-24265713-A-G
• rs4697055
• NM_001330751.2:c.-164-7446T>C

Your query was ambiguous. Multiple possible variants found:

• chr4-24265713-A-G
• chr4-24265713-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001330751.2(PPARGC1A):​c.-164-7446T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 152,020 control chromosomes in the GnomAD database, including 7,806 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.30 (7806 hom., cov: 31)
• Consequence: PPARGC1A NM_001330751.2 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.389
• Publications: 3 publications found

Genes affected

PPARGC1A (HGNC:9237): (PPARG coactivator 1 alpha) The protein encoded by this gene is a transcriptional coactivator that regulates the genes involved in energy metabolism. This protein interacts with PPARgamma, which permits the interaction of this protein with multiple transcription factors. This protein can interact with, and regulate the activities of, cAMP response element binding protein (CREB) and nuclear respiratory factors (NRFs). It provides a direct link between external physiological stimuli and the regulation of mitochondrial biogenesis, and is a major factor that regulates muscle fiber type determination. This protein may be also involved in controlling blood pressure, regulating cellular cholesterol homoeostasis, and the development of obesity. [provided by RefSeq, Jul 2008]

ENSG00000308193 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.85).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330751.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	PPARGC1A	NM_001330751.2		c.-164-7446T>C		intron	N/A	NP_001317680.1	Q9UBK2-3
	PPARGC1A	NM_001354825.2		c.-99-174078T>C		intron	N/A	NP_001341754.1	Q9UBK2-3
	PPARGC1A	NM_001354827.2		c.-99-174078T>C		intron	N/A	NP_001341756.1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ENSG00000308193	ENST00000832403.1		n.452-7446T>C		intron	N/A

Frequencies

GnomAD3 genomes AF: 0.302 AC: 45942 AN: 151900 Hom.: 7805 Cov.: 31

Gnomad AFR AF: 0.458

Gnomad AMI AF: 0.155

Gnomad AMR AF: 0.286

Gnomad ASJ AF: 0.239

Gnomad EAS AF: 0.461

Gnomad SAS AF: 0.293

Gnomad FIN AF: 0.254

Gnomad MID AF: 0.258

Gnomad NFE AF: 0.214

Gnomad OTH AF: 0.285

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.302 AC: 45979 AN: 152020 Hom.: 7806 Cov.: 31 AF XY: 0.306 AC XY: 22748 AN XY: 74296

African (AFR) AF: 0.458 AC: 18975 AN: 41442

American (AMR) AF: 0.286 AC: 4374 AN: 15272

Ashkenazi Jewish (ASJ) AF: 0.239 AC: 828 AN: 3466

East Asian (EAS) AF: 0.461 AC: 2381 AN: 5164

South Asian (SAS) AF: 0.291 AC: 1401 AN: 4814

European-Finnish (FIN) AF: 0.254 AC: 2676 AN: 10556

Middle Eastern (MID) AF: 0.260 AC: 76 AN: 292

European-Non Finnish (NFE) AF: 0.214 AC: 14529 AN: 67992

Other (OTH) AF: 0.283 AC: 598 AN: 2112

Alfa AF: 0.238 Hom.: 2497

Bravo AF: 0.313

Asia WGS AF: 0.333 AC: 1155 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.85
CADD	Benign	7.7
DANN	Benign	0.66
PhyloP100		0.39

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs4697055; hg19: chr4-24267336;